News

2015
29 June

HAI Sexual Harassment Policy
24 June

We Need a Reponsible R&D Model
23 June

Health Action International Launches New Brussels Office
16 June

Health Action International Criticises JURI Support for EU Trade Secrets Directive Report
15 June

End of Transparency: Paving the way for Trade Secrets in TTIP
14 April

How TTIP Could Damage Access to Affordable Medicines in the European Union
23 March

EU Trade Secrets Directive Threat to Free Speech, Health, Environment and Worker Mobility
15 March

Assessing the Nature, Extent and Impact of Regulation of Medicines Promotion
3 March

2014 Annual Report and Financial Statements
1 March

2014 Annual Report and Financial Statements
1 March

Donors
18 February

EU Clinical Trials Regulation: EMA Steers Away from Transparency by Misinterpreting Exception Provisions
4 February

The EU-US trade deal could leave Europeans sick
16 January

Innovative Global Study Launched to Improve Access to Insulin
1 January

HAI Europe Workplan 2015
2014
22 October

Retention of Medicines Policy in DG Health a Victory for Public Health Advocates
16 October

EMA’s Final Policy on Access to Clinical Data: Proactive Access to Some Data, But Strings Attached
14 October

EU Pharmacovigilance Public Hearings Should Be As Transparent and Independent as in US
29 September

Trading Away Access to Medicines – Revisited
29 September

Europe Seeks to Expand Big Pharma Monopoly at Expense of Poor People, Warn NGOs Ahead of TTIP Talks (2014)
12 September

Public Health in Danger with Move of Pharmaceutical Policy to DG Enterprise and Industry
1 September

Mapping External Reference Pricing Practices for Medicines
15 July

Providing Scientific Advice to Pharma Industry Undermines Independence of Regulatory Authorities
14 July

Investor-State Dispute Settlement in EU-US Trade Deal Risks Access to Affordable Medicines
24 June

EMA’s New Policy on Access to Clinical Data – About to Privatise Pharmaceutical Knowledge?
5 June

Variations in Prices and Reimbursement of Medicines in the European Union
22 May

HAI Europe Urges EMA Not to Backtrack on Commitments to Clinical Trial Data Transparency
22 May

Act Now or Face Catastrophic Post-antibiotic Era: Global Civil Society Coalition Issues Grave Warning to WHA
22 April

Declaration on Antibiotic Resistance (Antibiotic Resistance Coalition)
3 April

Health Action International Welcomes Adoption of New Clinical Trials Regulation by European Parliament